Jun 20, 2022 | Featured, Research News, Technology Updates
New potential diabetes treatment regenerates insulin-producing cells was written by Michael Irving for NewAtlas.com, 13 June 2022. An emerging way to treat diabetes is to repair or replace the cells in the body that naturally produce insulin. Swedish researchers have...
Jun 17, 2022 | Advocacy, Featured
FTC votes unanimously to increase scrutiny over pharmacy agent fees was reported by Dulan Lokuwithana for SeekingAlpha.com, 16 June 2022. The Federal Trade Commission (FTC) voted unanimously to adopt a policy statement stating its intention to more closely examine the...
Jun 8, 2022 | Featured, Research News, Technology Updates
More on Dexcom: Dexcom CEO Sayer on G7 FDA submission, developing a 15-day sensor, M&A plans was published by Ricky Zipp for MedTechDive.com, 7 June 2022. The executive spoke about the company’s discussions with the FDA on the G7 CGM system,...
Jun 6, 2022 | Featured, Research News, Technology Updates
ABBOTT NEWS US FDA approves Abbott’s FreeStyle Libre 3 system for diabetic patients was reported by MedicalDevice-Network.com, 1 June 2022. The US Food and Drug Administration (FDA) has granted clearance to Abbott’s next-generation FreeStyle...
May 30, 2022 | Featured, Research News, Technology Updates
How a Dexcom-Insulet combination would shake up the diabetes treatment industry was published by Ricky Zipp for MedTechDive.com, 25 May 2022. After last year’s barrage of deal-making in the medical device industry, there have been few acquisitions in...